PATENT CLAIM ANALYSIS

Application Number: 16027967
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["424", "179100"]

Abstract:
Provided herein are immunoconjugates comprising an anti-ROR1 antibody or an antigen-fragment fragment thereof and a drug moiety. These immunoconjugates are useful for treating ROR1 expressing cancers.

Claim (Index 21):
The immunoconjugate of  claim 16 , wherein the heavy chain and light chain of the antibody comprise the amino acid sequences of:\n a) SEQ ID NOs: 3 and 4, respectively; b) SEQ ID NOs: 3 and 49, respectively; c) SEQ ID NOs: 47 and 4, respectively; or d) SEQ ID NOs: 47 and 49, respectively.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11978122', '14517682', '12939533', '13796768', '15130667']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7963312160131741
- 35 USC 102 Novelty (BERT): 0.5494748283162227
- Combined Prediction Score: 0.771645577243479
- Mean Citation Score: 384.160708
- Max Citation Score: 410.674
- Similarity Product: 336.63275895905485

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test